Bartosz Chmielowski
Hematology & Oncology · The Regents of the University of California
Credentials: · · · · ·
History
Until 2008
Until 2005- Until 2002
- 1995
Akademia Medyczna W Wroclawiu
Research
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Nature · 2014 · 5,545 citations
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
New England Journal of Medicine · 2013 · 2,799 citations
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
New England Journal of Medicine · 2016 · 2,646 citations
55 papers
36 papers
- SN
29 papers
24 papers
17 papers · 2 as a resident
15 papers
15 papers · 14 as a resident
14 papers
Clinical trials
- 2009–2019
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
- 2008–2018
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
- 2024–2031
Site PI · Recruiting · Phase 3
Replimune, Inc.
- 2023–2026
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
Site PI · Recruiting · Phase 1, Phase 2
Georgiamune Inc